In addition, while experimental study found FGF21 protects against cardiac hypertrophy related to β-oxidation of fatty acids (FAs) in mice (19), previous clinical studies found that increased FGF21 level was associated with adverse cardiac alterations (20, 21). Here, FGF21 is linked to cardiac hypertrophy.